CMGHF 0.020    Updated: 07-08-2017 $CMGHF Last Trade:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
20
CMGHF 0.020    Updated: 07-08-2017 $CMGHF
Last Trade: 6/30/2017
Last 0.020   
Open 0.020
Previous Close 0.020
Day High / Low 0.020 / 0.020
Year High / Low 0.820 / 0.018
Volume 10,000
Projected Volume 10000 (16%)
# of Trades / Projected 1 / -
Dividend / Yield - / -
Abnormal Activity NONE
Abnormal Volume NO
Gap GAP UP
Candle NEUTRAL
Volatility Today MEDIUM
Volatility Yesterday MEDIUM
Price Relativity
From 40 Day High 87%
From 80 Day High 87%
From 150 Day High 53%
From 40 Day Low 217%
From 80 Day Low 217%
From 150 Day Low 217%
Pivot Analysis
Price Pivot $ 0.030
Day Resistance 1 $ 0.030
Day Support 1 $ 0.030
Day Resistance 2 $ 0.030
Day Support 2 $ 0.030
Consolidations
Short Term YES
Medium Term NO
Long Term YES
Volume Indicators
20 Day Avg Vol 64,275
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 56,554
Today / 150 Day Avg Vol ABOVE
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bearish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bullish
100 Day Trend bearish
Stochastics neutral
RSI bearish
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bearish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today MEDIUM
Volatility Index Yesterday MEDIUM
10 Day Volatility DECREASING
20 Day Volatility INCREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Scorpius Holdings Boosts Efficiency with New Cost Reduction Plan

Updated Category News Views 183

Scorpius Holdings Implements Significant Cost-Saving Strategies Scorpius Holdings, Inc. (NYSE American: SCPX), a notable player in the biomanufacturing landscape, has recently introduced a series of strategic cost-saving measures. These initiatives aim to reduce operational costs by more than $2 million annually, showcasing the company's commitment to enhancing its...

Continue Reading
McKesson's Strategic Shift: Selling Rexall and Well.ca

Updated Category News Views 122

McKesson Corporation Expands Focus on Healthcare Services IRVING, Texas - McKesson Corporation (NYSE: MCK), a leader in healthcare services with a market capitalization of $72.45 billion and annual revenue exceeding $330 billion, has officially completed the sale of its Rexall and Well.ca businesses to Birch Hill Equity Partners. This noteworthy decision allows McKesson...

Continue Reading
GSI Group Enhances Market with GenesisBPS Acquisition

Updated Category News Views 155

GSI Group Strengthens Its Portfolio GSI Group Holdings has made a significant move by acquiring GenesisBPS, an innovative designer and manufacturer of specialized benchtop blood processing equipment and laboratory consumables. This acquisition enhances GSI Group's expanding global sales platform, reinforcing its commitment to serving the life sciences, research and...

Continue Reading
Forecasting Growth in the Antidepressant Drugs Market

Updated Category News Views 156

Understanding the Antidepressant Drugs Market The Antidepressant Drugs Market is anticipated to undergo significant growth, with a projection to reach USD 26.9 billion by 2033. This upward trend reflects a compound annual growth rate (CAGR) of 3.3% from 2024 to 2033, highlighting the increasing reliance on these medications to treat depression. Antidepressants are...

Continue Reading
Inceptio Technology Introduces Strategic Vision for L4 Trucks

Updated Category News Views 227

A Visionary Approach to L4 Autonomous Trucking by Inceptio Technology Inceptio Technology is making significant strides in the field of autonomous trucking, sharing its detailed strategy for scaling Level 4 (L4) autonomous trucks. The company recently took center stage at the Next Truck 2025 conference, demonstrating its commitment to reshaping the future of...

Continue Reading